New Issue: Vivus prices $10 million direct placement of stock

By Devika Patel

Knoxville, Tenn., April 15 - Vivus, Inc. has priced a $10 million direct placement of shares, according to a prospectus supplement filed Tuesday with the Securities and Exchange Commission.

The company will sell 1,626,017 common shares at $6.15 apiece.

Proceeds will be used to fund clinical trials of the company's product candidates and for general corporate purposes.

Vivus, based in Mountain View, Calif., is a pharmaceutical company focused on treatments for obesity and sexual dysfunction.

Issuer:	Vivus, Inc.
Issue:	Common shares
Amount:	$10,000,004.55
Shares:	1,626,017
Price:	$6.15
Warrants:	No
Pricing date:	April 7
Settlement:	April 15
Stock symbol:	Nasdaq: VVUS
Stock price:	$6.02 at close April 7, $5.65 at close April 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.